Modified bone-marrow cells stop fractures in osteoporosis trial
Ten older women with osteoporosis received an infusion of their own modified bone-marrow cells in a small clinical trial. Before the treatment, participants suffered fractures every year or two, but after receiving the therapy, breaks from low-impact trauma occurred only once per decade on average. The study reported to Cell found that this one-time cell therapy sustained high efficacy for several years without side effects.
Ten older women with osteoporosis received an infusion of their own modified bone-marrow cells in a small clinical trial. Before the treatment, participants suffered fractures every year or two, but after receiving the therapy, breaks from low-impact trauma occurred only once per decade on average. The study reported to Cell found that this one-time cell therapy sustained high efficacy for several years without side effects.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.